Identification of a novel human papillomavirus type 16 E1 gene variant with potentially reduced oncogenicity

Journal of Medical Virology

Volumn 80, Issue 12, 2008, Pages 2134-2140

  Sabol, Ivan ^a   Matovina, Mihaela ^a   Gasperov, Nina Milutin ^a   Grce, Magdalena ^a,b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b NONE   (Croatia)

Author keywords

Cervical cancer development; E1 variant; E6 350G variant; Human papillomavirus 16

Indexed keywords

PROTEIN E6; PROTEIN E7;

ADOLESCENT; ADULT; AGED; ARTICLE; ATYPICAL SQUAMOUS CELL OF UNKNOWN SIGNIFICANCE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE DUPLICATION; GENE E1; GENE IDENTIFICATION; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; NUCLEOTIDE SEQUENCE; PRECANCER; PREVALENCE; SEQUENCE ANALYSIS; SQUAMOUS CELL; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS GENOME; VIRUS MUTATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CERVIX UTERI; CLUSTER ANALYSIS; DNA, VIRAL; FEMALE; GENE DUPLICATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 57349157001     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21304     Document Type: Article

References (41)

1. Amin AA, Titolo S, Pelletier A, Fink D, Cordingley MG, Archambault J. 2000. Identification of domains of the HPV11 E1 protein required for DNA replication in vitro. J Virol 272:137-150.
2. Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, Tommasino M, Zehbe I, Sherman L. 2007. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J Med Virol 79:1751-1760.
3. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170:1077-1085.
4. Bernard HU, Calleja-Macias IE, Dunn ST. 2006. Genome variation of human papillomavirus types: Phylogenetic and medical implications. Int J Cancer 118:1071-1076.
5. Bontkes HJ, van Duin M, deGruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, Sinnott P, Stern PL. 1998. HPV 16 infection and progression of cervical intraepithelial neoplasia: Analysis of HLA polymorphism and HPV16 E6 sequence variants. Int J Cancer 78:166-171.
6. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
7. Brady CS, Duggan-Keen MF, Davidson JA, Varley JM, Stern PL. 1999. Human papillomavirus type 16 variants in cervical carcinoma: Relationship to host genetic factors and clinical parameters. J Gen Virol 80:3233-3240.
8. Campo MS, editor. 2006. Papillomavirus research - From natural history to vaccines and beyond. UK: Caister Academic Press. 424 pp.
9. Chow LT, Broker TR. 1994. Papillomavirus DNA replication. Intervirology 37:150-158.
10. Chow LT, Broker TR. 2006. Mechanisms and regulation of papillomavirus replication. In: Campo MS, editor. Papillomavirus research - From natural history to vaccines and beyond. UK: Norfolk, Kaister Academic Press. pp. 53-71.
11. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003a. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101-105.
12. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003b. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88:63-73.
13. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
14. Dong X, Zhou W, Pfister H. 2000. Presence of genetic rearrangements in E1/E2 regions of episomal HPV 16 isolates from cervical carcinomas. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 14:5-8. [In Chinese].
15. Gargiulo F, De Francesco MA, Schreiber C, Ciravolo G, Salinaro F, Valloncini B, Mancaa N. 2007. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res 125:176-182.
16. Giannoudis A, Herrington CS. 2001. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193:295-302.
17. Grce M, Husnjak K, Bozikov J, Magdic L, Zlacki M, Lukac J, Fistonic I, Sikanic-Dugic N, Pavelic K. 2001. Evaluation of genital human papillomavirus infections by polymerase chain reaction among Croatian women. Anticancer Res 21:579-584.
18. Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I. 2006. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 15:820-822.
19. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92:464-474.
20. Ho GY, Palan PR, Basu J, Romney SL, Kadish AS, Mikhail M, Wassertheil-Smoller S, Runowicz C, Burk RD. 1998. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 78:594-599.
21. Hughes FJ, Romanos MA. 1993. El protein of human papillomavirus is a DNA helicase/ATPase. Nucleic Acids Res 21:5817-5823.
22. Ljubojevic N, Babic S, Audy-Jurkovic S, Ovanin-Rakic A, Jukic S, Babic D, Grubisic G, Radakovic B, Ljubojevic-Grgec D. 2001. Improved national Croatian dignostic and therapeutic guidelines for premalignant lesions of the uterine cervix with some cost-benefit aspects. Coll Antropol 25:467-474.
23. Lukaszuk K, Liss J, Wozniak I, Emerich J, Wojcikowski C. 2003. Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J Clin Microbiol 41:608-612.
24. Moreno V, Munoz N, Bosch FX, de Sanjose S, Gonzalez LC, Tafur L, Gili M, Izarzugaza I, Navarro C, Vergara A, Viladiu P, Ascunce N, Shah KV. 1995. Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 4:459-467.
25. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD. 1991. Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study. Int J Cancer 49:6-13.
26. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJF, Meijer CJLM. 2003. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
27. Nindl I, Rindfleisch K, Kotz B, Schneider A, Durst M. 1999. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intraepithelial neoplsia and cervical cancer. Int J Cancer 82:203-207.
28. Ovanin-Rakic A, Pajtler M, Stankovic T, Audy-Jurkovic S, Ljubojevic N, Grubisic G, Kuvacic I. 2003. Classification of cervical cytological smears "Zagreb 2002". Modification of the classification "Zagreb 1990" and "NCI Bethesda 2001". Gynaecol Perinatol 12:148-153. [In Croatian].
29. Sasagawa T, Basha W, Yamazaki H, Inoue M. 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10:45-52.
30. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG. 1985. Human papillomavirus Type 16 DNA sequence. Virology 145:181-185.
31. Shih-Yen C, Bernard HU, Chi-Keong O, Shih-Ping C, Hofmann B, Delius H. 1992. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: A showcase for the molecular evolution of DNA viruses. J Virol 66:5714-5725.
32. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bultmann B. 2004. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol 42:3176-3184.
33. Swindle CS, Engler JA. 1998. Association of the human papillomavirus type 11 E1 protein with histone H1. J Virol 72:1994-2001.
34. van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ, van den Tweel J. 2002. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 156:158-164.
35. van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomer JM. 2000. Analysis of human papillomavirus type 16 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81:317-325.
36. Wilson VG, West M, Woytek K, Rangasamy D. 2002. Papillomavirus E1 proteins: Form, function, and features. Virus Genes 24:275-290.
37. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. 1997. Human papilloma type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol 71:2463-2472.
38. Yasugi T, Benson JD, Sakai H, Vidal M, Howley PM. 1997. Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J Virol 71:891-899.
39. Zehbe I, Wilander E, Delius H, Tommasino M. 1998a. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833.
40. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. 1998b. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441-1442.
41. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E, Tommasino M. 2001. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94:711-716.